Procurement Summary
Country : Poland
Summary : Successive Delivery of the Biological Drug Dupilumab for the Treatment of Patients with a Severe Form of Atopic Dermatitis Ad and Drugs for Moderate and Severe Treatment of Psoriasis.
Deadline : 20 Jun 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 67129942
Document Ref. No. : 291479-2022
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Document Type: Corigendum/Additional Information (Please Depder Tender Document)
Title: Successive Delivery of Biological Dupilumab for the treatment of patients with a severe form of atopic dermatitis AD and drugs for moderate treatment and severe psoriasis. Placing Reference number: 105. Dziewspzoz-ZP-2612-9/UE/2022
Contract Type: Supplies
Description: The subject of the contract is the successive delivery of the Biological Dupilumab Biological drug for the treatment of patients with a severe form of atopic dermatitis AD and drugs for moderate treatment and severe form of psoriasis of crying psoriasis in adults, covered by the program
33690000 - Various Medicinal Products
Authority Type: Other
Type of Procedure: Open Procedure
Regulation: European Union
Bid Type: Submission for All Lots
DOC TITLE: Various Medicinal Products
Dispatch Date: 2022-05-26
Publish Date: 2022-05-31
Submission date: 2022-06-20
Documents
Tender Notice